The Japanese government has given a grant amounting to over K3.8 million (approximately US$600,000) to the Association for Aid and Relief, Japan (AAR Japan).
The money is for facilitating the implementation of phase three of the HIV/AIDS project in Kafue district.
Japanese Ambassador to Zambia Kiyoshi Koinuma said the project will focus on the establishment of a sustainable framework for the provision of antiretroviral therapy (ART) and other forms of support towards people living with HIV/AIDS and those at risk of contracting the disease.
Ambassador Koinuma stated that the project will include the upgrading of ART centres in the district at Mount Makulu, Nangongwe and Mwembeshi Health Centres, improving data management for HIV/AIDS patients, training of health volunteers and sensitising people on HIV/AIDS and ART related issues.
The Japanese Ambassador signed the grant contract on behalf of the government of Japan while AAR Japan Acting Country Representative Ryota Hirama signed on behalf of his organisation in Lusaka today.
Ambassador Hirama hoped the activities of AAR Japan will continue to contribute towards the wellbeing of the vulnerable people in the country and further enhance the strengthening of the cordial relations that exist between the people of Japan and Zambia.
And Mr. Hirama has praised the Japanese government for the provision of the grant which he said will immensely help the most vulnerable groups in the implementation district.
He promised to be extremely committed to the cause for which the grant has been provided.
Mr. Hirama also commended the Zambian government and other concerned government agencies for facilitating the organisation’s smooth operations during the implementation of the project.
AAR Japan is a Japanese Non-governmental Organisation that specialises in the provision of aid assistance to vulnerable groups in various countries across the global.
The organisation is currently implementing projects in 15 countries around the world including five African countries that include Zambia.